Identifying Those Remembered

Last year, two Denver scientists theorized that a clinical instrument used to spot cancer mutations could speed up the normally tedious DNA identification process. Then the attacks of Sept. 11 occurred, and their work suddenly took on a sense of urgency. When the National Institute of Justice (NIJ) sent out a countrywide plea for information on new technologies that could assist in the investigation at Ground Zero, Phil Danielson, assistant professor of molecular biology at the University of Den

Written byKelli Miller
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"[Sept. 11] prompted us to cut to the chase on the research front and show that our approach really would work," says Danielson. "In the absence of that added pressure it probably would have taken one to two years to get to where we are now." In a pilot study using San Jose, Calif.-based Transgenomic's WAVE Nucleic Acid Fragment Analysis System, Danielson and Shelton demonstrated that WAVE profiling, one of the most effective technologies for rapidly identifying new genetic mutations potentially involved in the formation of human tumors, could quickly and cheaply perform a kind of DNA analysis called mitotyping. This technique and other advances in DNA forensics promise to speed DNA identification at disaster sites and war zones, and in criminal investigations.

That is when mitochondrial DNA (mtDNA) comes into play, says Terry Melton, president and founder of State College, Pa.-based Mitotyping Technologies. Melton is on an advisory panel ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies